Log in or Sign up for Free to view tailored content for your specialty!
Primary Care Optometry News
Wearing reading glasses boosted income by a third in low-income communities
Providing free reading glasses significantly increased self-reported monthly earnings and quality of life among individuals with presbyopia in low-income communities in Bangladesh, according to study results published in PLOS ONE.
Consider pros, cons of presbyopia eye drops
BOSTON — Eye drops are an “exciting” technology for presbyopia in the right candidates, but ophthalmologists must educate patients on their drawbacks, according to a speaker here.
Log in or Sign up for Free to view tailored content for your specialty!
One-third of Americans are unaware of solar eclipse health risks
A survey conducted by The Ohio State University Wexner Medical Center found that nearly 30% of Americans do not know that looking directly at a solar eclipse without protection can cause permanent eye damage.
EssilorLuxottica, WCO partner to raise awareness about presbyopia
EssilorLuxottica and the World Council of Optometry have announced a global partnership to raise awareness about presbyopia and establish standards of care for management of the condition.
WCO launches Competency Framework for Optometry
The World Council of Optometry has announced the launch of its Competency Framework for Optometry, a resource designed to define essential skills, knowledge and abilities for the profession and streamline optometric education worldwide.
Q&A: Optometrist discusses eye safety, solar retinopathy ahead of April total eclipse
Looking directly at the sun is never safe, but the temptation is high during a rare event like a solar eclipse.
FDA approves Ultomiris for neuromyelitis optica spectrum disorder
The FDA approved Ultomiris for the treatment of adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder, according to a press release from Alexion.
Clinical study results link Neurolens to reduction in headache symptoms
NEW YORK — Patients with moderate to severe headache experienced a clinically significant reduction in headache symptoms after wearing Neurolens contoured prism technology, a company executive said at Vision Expo East.
Lumevoq shows sustained efficacy, safety 4 years after one-time LHON treatment
Lumevoq demonstrated sustained efficacy and a positive safety profile at 4 years after a one-time injection of the gene therapy in patients with Leber hereditary optic neuropathy, according to a press release from GenSight Biologics.
VIDEO: New treatment options on the horizon for patients with presbyopia
WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Sheri L. Rowen, MD, discusses new treatment options for patients with presbyopia.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read